-Phase 1b study will investigate the efficacy of REVTx-99 on nasal symptoms elicited by nasal allergen challenge- -Top-line data anticipated...
NEW YORK, NY, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a...
Efforts feature mental health advocate and expert Dr. Melissa ShepardMALVERN, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
EyeGene expected to utilize TriLink’s CleanCap® technology and modified UTP manufactured by TriLink in the production of its EG-COVID mRNA...
ROSELAND, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
FLORHAM PARK, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
The PURE EP™ System is validated in multi-center study as superior to conventional sources of intracardiac signalsWestport, CT, Oct. 04,...
CALGARY, Alberta, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”), (CSE: MGW)...
JERSEY, Channel Islands, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment...
BELTSVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021PRINCETON, N.J., Oct. 04,...
~ New $300 million facility, combined with Company’s cash balance as of June 30, 2021, provides access to over $900...
The company also announced the closing of a $5 million financing round from U.S. institutions. Both parties to combine their...
Selecta’s ImmTOR™ platform enhances transgene expression and addresses adeno-associated virus (AAV) vector immunogenicity constraints to deliver transformative therapiesWATERTOWN, Mass., Oct....
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
Former GSK Executive Stephen Pyke will lead and direct the operational execution and development of all facets of Parexel’s clinical...
FREMONT, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the company has...
Senior leader with extensive global rare disease commercialization experienceTop-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated...
BANNOCKBURN, Ill., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the largest independent...
LEXINGTON, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
